Lists

Rachel Haurwitz

Rachel Haurwitz

Cofounder and CEO, Caribou Biosciences
FRANCE VIVATECHNOLOGY PORTRAIT

Biotech entrepreneur Rachel Haurwitz is at the forefront of advances in gene editing. As the CEO and cofounder of Caribou Biosciences, Haurwitz oversees work on a host of promising medical innovations, such as T cell therapies, other gene-edited cell therapies, and engineered gut microbes. Using the CRISPR (clustered regularly interspaced short palindromic repeats) technology she learned while earning her PhD at University of California Berkeley with CRISPR pioneer Jennifer Doudna (who cofounded Caribou), Haurwitz holds several patents and patent applications covering multiple CRISPR-based technologies. In addition to Caribou’s work on medical applications of CRISPR, the company is also working on antimicrobial resistance, food scarcity and vaccine shortages, with the slogan “engineering any genome, at any site, in any way.”

Scroll to Top